Treatment-resistant depression patients showed a simultaneous increase in cortisol and IL-6 levels [10], as well as a high correlation between a decrease in the expression of the glucocorticoid receptor (GRa) and the upregulation of the inflammatory genes in monocytes [11]. Here, NR3C1 is linked to depressive disorder.